ライフサイエンスコーパス: impaired renal function

1 ion, dyslipidemia, the metabolic syndrome or impaired renal function.

2 ative stress, mitochondrial dysfunction, and impaired renal function.

3 eas serum MMA showed notable, increases with impaired renal function.

4 ced nephrotoxicity in selected patients with impaired renal function.

5 xaban-treated patients with normal or mildly impaired renal function.

6 na, hospital admission for heart failure, or impaired renal function.

7 described as a sensitive marker in detecting impaired renal function.

8 development of diabetes, and development of impaired renal function.

9 inflammation, apoptosis, cyst formation, and impaired renal function.

10 It is an early marker of impaired renal function.

11 sessment of concomitant valve disease and/or impaired renal function.

12 ctions, and all-cause death in patients with impaired renal function.

13 an be elevated by overweight, older age, and impaired renal function.

14 dly increased risk that is independent of an impaired renal function.

15 because of the complexity of their care and impaired renal function.

16 anemia was more pronounced in patients with impaired renal function.

17 ns including retroperitoneal haemorrhage and impaired renal function.

18 1,969 patients with AHF and mild to moderate impaired renal function.

19 MA ratio was lower in people with moderately impaired renal function.

20 xtrin, which may accumulate in patients with impaired renal function.

21 and lactate dehydrogenase levels, as well as impaired renal function.

22 ts hospitalized for acute heart failure with impaired renal function.

23 ated by enhanced inflammation, fibrosis, and impaired renal function.

24 may promote Pi homeostasis in patients with impaired renal function.

25 in patients with ADHF and is associated with impaired renal function.

26 out, including those with mild to moderately impaired renal function.

27 with maternal drug-treated hypertension and impaired renal function.

28 in increased drug exposures in patients with impaired renal function.

29 l patients had hyperdynamic septic shock and impaired renal function.

30 tatus; however, concentrations increase with impaired renal function.

31 increased blood lead and cadmium levels, and impaired renal function.

32 emetrexed in cancer patients with normal and impaired renal function.

33 pears to be especially true in patients with impaired renal function.

34 tive glomerulonephritis and in patients with impaired renal function.

35 ASPs, 210 were concordant for diabetes with impaired renal function.

36 on equations in people with normal or mildly impaired renal function.

37 patients with normal, mildly, and moderately impaired renal function.

38 that these elevations were a consequence of impaired renal function.

39 The prognostic value of impaired renal function according to CKD classification

40 Impaired renal function after coronary artery bypass gra

41 An impaired renal function also leads to 1,25-vitamin D3 de

42 Impaired renal function and albuminuria, common among pe

43 The combination of impaired renal function and bilateral disease adversely

44 ial space due to kidney injury, resulting in impaired renal function and chronic kidney disease.

45 70 and with medical co-morbidities, such as impaired renal function and diabetes.

46 that podocyte Nox5 has an important role in impaired renal function and hypertension.

47 In addition, Impaired renal function and morphologic lesions in rats

48 ients than before are receiving diagnoses of impaired renal function and nephrosclerosis-age-associat

49 actor for vascular disease, is elevated with impaired renal function and poor vitamin B-12 status, wh

50 Efforts to identify patients with impaired renal function and to preserve renal function b

51 unction, fair (74+/-7%) in those with mildly impaired renal function, and poor (52+/-7%) in patients

52 Diabetes mellitus, impaired renal function, and reduced 6-minute walk dista

53 t atrial dilatation, valvular heart disease, impaired renal function, and serum magnesium, was identi

54 PAD patients often have impaired renal function, and the blood concentration of

55 RSA) bloodstream infections in patients with impaired renal function are reflected in a recent packag

56 en shown to be as effective in patients with impaired renal function as in those with preserved renal

57 With the increase in patients having impaired renal function at liver transplant due to MELD,

58 bination of captopril and infection may have impaired renal function because these mice had increased

59 nimals, 42.5% transgene-negative animals had impaired renal function (blood urea nitrogen > 50 mg/dl)

60 (BNP, r = 0.58, NT-proBNP, r = 0.73) versus impaired renal function (BNP, r = 0.48, NT-proBNP, r = 0

61 onths of age, RC/RC mice had large cysts and impaired renal function, but when treated with VX-809 be

62 A composite of death, dialysis, or sustained impaired renal function by day 30 after surgery did not

63 ate that although 25 to 30% of patients with impaired renal function can recover glomerular filtratio

64 lerosis and is associated with hypertension, impaired renal function, congestive heart failure, and a

65 In patients with impaired renal function creatinine/eGFR levels remained

66 r 1.73 m(2); n=722) to 57%-61% with severely impaired renal function (eGFR<30 ml/min per 1.73 m(2); n

67 Specificity decreased with impaired renal function from 93%-95% with normal functio

68 Impaired renal function, gastrointestinal disorders, and

69 110 and 75 mg BID in patients with normal or impaired renal function (glomerular filtration rate >80

70 aive patients with measurable disease and an impaired renal function (glomerular filtration rate < 60

71 on (group 1) or at least one examination and impaired renal function (group 2).

72 Control groups with normal and impaired renal function (groups 3 and 4) without history

73 rization in the presence of normal or mildly impaired renal function had a beneficial effect on blood

74 Patients with ALD and impaired renal function have a higher risk of graft loss

75 tes mellitus (hazard ratio, 2.322; P=0.019), impaired renal function (hazard ratio, 0.975; P=0.006),

76 ascular beds affected with atherosclerosis), impaired renal function, heart failure, and/or diabetes

77 Most of them had impaired renal function, hypoalbuminemia, concurrent inf

78 with kidney allograft loss after PAK include impaired renal function in the 3 months before PAK, prot

79 I is associated with increased mortality and impaired renal function in the first postoperative year.

80 Impaired renal function, increased age, and pharmacologi

81 The relationship between kidney size and impaired renal function induced by shock-wave lithotrips

82 vular AF at moderate to high risk of stroke, impaired renal function is a potent predictor of stroke

83 Impaired renal function is associated with poor outcomes

84 Previous studies have demonstrated that impaired renal function is associated with poorer clinic

85 maintenance aspirin and clopidogrel therapy, impaired renal function is associated with reduced clopi

86 let therapies among patients with stroke and impaired renal function is limited and inconsistent.

87 nitive dysfunction is solely attributable to impaired renal function is unclear.

88 atment were resistant hypertension (n = 25), impaired renal function, (n = 50), and both (n = 25).

89 ented that renal vasoconstriction leading to impaired renal function occurs during cirrhosis, our dat

90 ed fibrinolytic efficacy among patients with impaired renal function or by the presence of congestive

91 llation (P < .001), diabetes (P < .001), and impaired renal function (P < .001); and had higher N-ter

92 .2 to 2 mg/dl), and severely (Cr >2.0 mg/dl) impaired renal function (p < 0.001) and in patients with

93 Impaired renal function predicts increased mortality in

94 isk of developing CKD, along with those with impaired renal function pretransplantation or early post

95 advocating limited ICM use in patients with impaired renal function, preventing crucial radiographic

96 ltrex, GlaxoSmithKline) and one patient with impaired renal function received oral 1 g tid.

97 Patients with normal, rather than impaired, renal function received greater benefit from t

98 Patients with impaired renal function (serum creatinine >1.4 mg/dL or

99 which liver transplantation candidates with impaired renal function should undergo liver transplant

100 pheral arterial, cardiovascular disease, and impaired renal function significantly so, among HIV-infe

101 Poor glycaemic control and impaired renal function substantially increased the risk

102 the US alone, more than 250,000 people have impaired renal function that necessitates treatment by d

103 n pediatric renal transplant recipients with impaired renal function, the use of MMF at the recommend

104 For patients with impaired renal function, these changes were not reversib

105 cates beta-lactam therapy, particularly with impaired renal function, though no studies have reported

106 (ASPs) from 247 families ascertained through impaired renal function to identify type 2 diabetes loci

107 P < 0.05) higher percentage of subjects with impaired renal function treated with febuxostat 80 mg (4

108 Impaired renal function was associated with increased mo

109 Impaired renal function was defined as GFR less than 60

110 Impaired renal function was determined via urinary album

111 The effects of 4SC-101 on impaired renal function were examined in a model of 5/6

112 ients with normal renal function, those with impaired renal function were older, were more often wome

113 Shorter fasting times and impaired renal function were significantly associated wi

114 infarction, peripheral arterial disease, and impaired renal function were significantly more prevalen

115 Important predictors of death include impaired renal function, worse functional class, male ge

116 We hypothesized that impaired renal function would also be associated with po